The results showed that under the action of sorafenib, the level of ROS in silenced ORMDL3 liver cancer cells was significantly higher than that of the control group (Fig. 4A), that is, silencing ORMDL3 can make the level of oxidative stress to increase in liver cancer cells. The gene discussed is ORMDL3; the disease is liver cancer.